1,032
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Comparison of office, home and ambulatory blood pressure measurements in hypertensive and suspected hypertensive SWICOS participants

, , , , , , , & show all
Article: 2234496 | Received 16 Dec 2022, Accepted 03 Jul 2023, Published online: 14 Jul 2023

References

  • Stergiou GS, Palatini P, Parati G, et al. 2021 European society of hypertension practice guidelines for office and out-of-office blood pressure measurement. J Hypertens. 2021;39(7):1–10.
  • Whelton PK, Chen J, Krousel-Wood M. Lessons learned from systolic blood pressure intervention trial. Curr Opin Cardiol. 2017;32(4):1–10. doi: 10.1097/HCO.0000000000000396.
  • Parati G, Agostoni P, Basnyat B, et al. Clinical recommendations for high altitude exposure of individuals with pre-existing cardiovascular conditions: a joint statement by the european society of cardiology, the council on hypertension of the European society of cardiology, the European society of hypertension, the international society of Mountain medicine, the Italian society of hypertension and the Italian society of Mountain medicine. Eur Heart J. 2018;39(17):1546–1554. doi: 10.1093/eurheartj/ehx720.
  • Parati G, Stergiou GS, Bilo G, et al. Home blood pressure monitoring: methodology, clinical relevance and practical application: a 2021 position paper by the working group on blood pressure monitoring and cardiovascular variability of the European society of hypertension. J Hypertens. 2021;39(9):1742–1767. doi: 10.1097/HJH.0000000000002922.
  • Iemitsu M, Maeda S, Otsuki T, et al. Arterial stiffness, physical activity, and atrial natriuretic peptide gene polymorphism in older subjects. Hypertens Res. 2008;31(4):767–774. doi: 10.1291/hypres.31.767.
  • O’Brien E, Parati G, Stergiou G. Ambulatory blood pressure measurement: what is the international consensus? Hypertension. 2013;62(6):988–994. doi: 10.1161/HYPERTENSIONAHA.113.02148.
  • Parati G, Stergiou GS, Asmar R, et al. European society of hypertension guidelines for blood pressure monitoring at home: a summary report of the second international consensus conference on home blood pressure monitoring. J Hypertens. 2008;26(8):1505–1526. doi: 10.1097/HJH.0b013e328308da66.
  • Parati G, Stergiou G, O’Brien E, et al. European society of hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens. 2014;32(7):1359–1366. doi: 10.1097/HJH.0000000000000221.
  • Hansen TW, Jeppesen J, Rasmussen S, et al. Ambulatory blood pressure monitoring and risk of cardiovascular disease: a population based study. Am J Hypertens. 2006;19(3):243–250. doi: 10.1016/j.amjhyper.2005.09.018.
  • Myers MG, Kaczorowski J. Are automated office blood pressure readings more variable than home readings? Hypertension. 2020;75(5):1179–1183. doi: 10.1161/HYPERTENSIONAHA.119.14171.
  • Drawz PE, Abdalla M, Rahman M. Blood pressure measurement: clinic, home, ambulatory, and beyond. Am J Kidney Dis. 2012;60(3):449–462. doi: 10.1053/j.ajkd.2012.01.026.
  • Schoenenberger AW, Muggli F, Parati G, et al. Protocol of the Swiss longitudinal cohort study (SWICOS) in rural Switzerland. BMJ Open. 2016;6(11):e013280. doi: 10.1136/bmjopen-2016-013280.
  • Topouchian J, Agnoletti D, Blacher J, et al. Validation of four devices: Omron M6 comfort, Omron HEM-7420, withings BP-800, and polygreen KP-7670 for home blood pressure measurement according to the European society of hypertension international protocol. Vasc Health Risk Manag. 2014;10:33–44. doi: 10.2147/VHRM.S53968.
  • Horvath IG, Nemeth A, Lenkey Z, et al. Invasive validation of a new oscillometric device (arteriograph) for measuring augmentation index, central blood pressure and aortic pulse wave velocity. J Hypertens. 2010;28(10):2068–2075. doi: 10.1097/HJH.0b013e32833c8a1a.
  • Baulmann J, Schillings U, Rickert S, et al. A new oscillometric method for assessment of arterial stiffness: comparison with tonometric and piezo-electronic methods. J Hypertens. 2008;26(3):523–528. doi: 10.1097/HJH.0b013e3282f314f7.
  • Visseren FLJ, Mach F, Smulders YM, et al. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3227–3337. doi: 10.1093/eurheartj/ehab484.
  • Pappaccogli M, Di Monaco S, Perlo E, et al. Comparison of automated office blood pressure with office and out-off-office measurement techniques. Hypertension. 2019;73(2):481–490. doi: 10.1161/HYPERTENSIONAHA.118.12079.
  • Alwan H, Ehret G, Ponte B, et al. Heritability of ambulatory and office blood pressure in the Swiss population. J Hypertens. 2015;33(10):2061–2067. doi: 10.1097/HJH.0000000000000681.
  • de la Sierra A, Vinyoles E, Banegas JR, et al. Prevalence and clinical characteristics of white-coat hypertension based on different definition criteria in untreated and treated patients. J Hypertens. 2017;35(12):2388–2394. doi: 10.1097/HJH.0000000000001493.
  • Karnjanapiboonwong A, Anothaisintawee T, Chaikledkaew U, et al. Diagnostic performance of clinic and home blood pressure measurements compared with ambulatory blood pressure: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2020;20(1):491. doi: 10.1186/s12872-020-01736-2.
  • Ntineri A, Niiranen TJ, McManus RJ, et al. Ambulatory versus home blood pressure monitoring: frequency and determinants of blood pressure difference and diagnostic disagreement. J Hypertens. 2019;37(10):1974–1981. doi: 10.1097/HJH.0000000000002148.
  • Groenland EH, Vendeville JAC, Bemelmans RHH, et al. Smartphone application-assisted home blood pressure monitoring compared with office and ambulatory blood pressure monitoring in patients with hypertension: the AMUSE-BP study. Hypertension. 2022;79(10):2373–2382. doi: 10.1161/HYPERTENSIONAHA.122.19685.
  • Narita K, Hoshide S, Kario K. Association of home and ambulatory blood pressure with cardiovascular prognosis in practice hypertensive outpatients. Hypertension. 2023;80(2):451–459. doi: 10.1161/HYPERTENSIONAHA.122.20178.
  • Townsend RR. Out-of-office blood pressure monitoring: a comparison of ambulatory blood pressure monitoring and home (self) monitoring of blood pressure. Hypertension. 2020;76(6):1667–1673. doi: 10.1161/HYPERTENSIONAHA.120.14650.
  • Briasoulis A, Androulakis E. Is white-coat hypertension associated with increased cardiovascular and mortality risk? Reply. J Hypertens. 2016;34(8):1658–1659. doi: 10.1097/HJH.0000000000000984.
  • Mancia G, Facchetti R, Quarti-Trevano F, et al. Antihypertensive drug treatment in white-coat hypertension: data from the plaque HYpertension lipid-lowering Italian study. J Hypertens. 2022;40(10):1909–1917. doi: 10.1097/HJH.0000000000003176.
  • Banegas JR, Ruilope LM, Williams B. Ambulatory blood pressure and mortality. N Engl J Med. 2018;379(13):1287–1288. doi: 10.1056/NEJMc1809851.
  • Yang WY, Melgarejo JD, Thijs L, et al. Association of office and ambulatory blood pressure with mortality and cardiovascular outcomes. JAMA. 2019;322(5):409–420. doi: 10.1001/jama.2019.9811.
  • Shimbo D, Abdalla M, Falzon L, et al. Studies comparing ambulatory blood pressure and home blood pressure on cardiovascular disease and mortality outcomes: a systematic review. J Am Soc Hypertens. 2016;10(3):224–234 e17. doi: 10.1016/j.jash.2015.12.013.
  • Sheppard JP, Nicholson BD, Lee J, et al. Association between blood pressure control and coronavirus disease 2019 outcomes in 45418 symptomatic patients with hypertension: an observational cohort study. Hypertension. 2021;77(3):846–855. doi: 10.1161/HYPERTENSIONAHA.120.16472.
  • Blood Pressure Lowering Treatment Trialists C. Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis. Lancet. 2021;397:1625–1636.
  • BFS. BfS. Schweizerische Gesundheitsbefragung 2017. Neuchâtel: BFS; 2018.